REDDYNUX fondaparinux sodium 2.5 mg/0.5 mL solution for injection pre-filled syringe

Active ingredient:

fondaparinux sodium, Quantity: 2.5 mg

Available from:

Dr Reddys Laboratories Australia Pty Ltd

INN (International Name):

Fondaparinux sodium

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium chloride; water for injections

Administration route:

Subcutaneous

Units in package:

2, 10, 20

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery.,Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing abdominal surgery who are at risk of thromboembolic complications.

Product summary:

Visual Identification: Clear and colorless to slightly yellow solution; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2015-02-16